AKT1 and neoplasm: It binds to integrin receptors (αvβ3, αvβ5, α6β4) [39,71] that are present on the surface of tumor cells and vascular endothelium, which allows regulation of signaling pathways (PI3K-AKT, FAK) [69,71].